Shlomi Kleinman
Tel Aviv Sourasky Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shlomi Kleinman.
Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology | 2012
Vadim Reiser; Michael Alterman; Benjamin Shlomi; Josephine Issakov; Yaniv Dagan; Shlomi Kleinman; Amir Shuster; Ilana Kaplan
Nodular fasciitis is a benign non-neoplastic myofibroblastic proliferation, involving the head in 7% to 20% of cases. Intravascular fasciitis (IVF) is a rare variant, with a unique intravascular growth pattern. Only 4 maxillofacial cases have been previously reported. We describe a 58-year-old woman with a rapidly growing, hard, mobile buccal submucosal swelling. CT scans identified a well-defined, 1.7-cm isodense lesion, located between the mental foramen and masseter muscle, which was excised under general anesthesia. A well-defined cellular nodular mass was composed of bland spindle cells, in a densely vascularized, focally myxoid matrix, involving an arterial lumen, and extending into adjacent tissues. Mitoses were rare. Immunohistochemistry was positive for smooth muscle actin, negative for keratins, S-100, epithelial membrane antigen, caldesmon, p53 and Alk. CD31 and CD34 were positive only in the vascular component, supporting the diagnosis of intravascular fasciitis.
European Journal of Internal Medicine | 2013
Tal Sella; Ben Boursi; Amira Gat-Charlap; Ilan Aroch; Eliezer Liberman; Menachem Moshkowitz; Ehud Miller; Eyal Gur; Roy Inbar; Arye Blachar; Nicola J. Mabjeesh; Olivia Rosenfeld; Fanny Sperber; Vadim Reiser; Shlomi Kleinman; Ariel J. Jaffa; Miki Bloch; Mati Ormianer; Inna Naumov; Diana Kazanov; Sarah Kraus; Lior Galazan; Nadir Arber
BACKGROUND Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality. METHODS We aimed to describe the experience of an integrated cancer prevention center in screening an asymptomatic population for the presence of neoplasia. One-thousand consecutive asymptomatic, apparently healthy adults, aged 20-80 years, were screened for early detection of 11 common cancers that account for 70-80% of cancer mortality. RESULTS Malignant and benign lesions were found in 2.4% and 7.1% of the screenees, respectively. The most common malignant lesions were in the gastrointestinal tract and breast followed by gynecological and skin. The compliance rate for the different screening procedures was considerably higher than the actual screening rate in the general Israeli population - 78% compared to 60% for mammography (p<0.001) and 39% compared to 16% for colonoscopy (p<0.001). Advanced age, family history of cancer and certain lifestyle parameters were associated with increased risk. Moreover, polymorphisms in the APC and CD24 genes indicated high cancer risk. When two of the polymorphisms existed in an individual, the risk for a neoplastic lesion was extremely high (OR 2.3 [95% CI 0.94-5.9]). CONCLUSIONS One stop shop screening for 11 common cancers in the setting of a multidisciplinary outpatient clinic is feasible and can detect cancer at an early stage.
International Journal of Oral and Maxillofacial Surgery | 2018
A. Shuster; V. Reiser; L. Trejo; C. Ianculovici; Shlomi Kleinman; Ilana Kaplan
The purpose of this study was to compare the histopathological parameters of chronic/suppurative osteomyelitis, medication-related osteonecrosis of the jaw (MRONJ), and osteoradionecrosis (ORN), and to examine the hypothesis that distinct histological features can be related to a specific disease, allowing for diagnosis based on microscopic evaluation alone. One hundred and ten samples were reviewed by two examiners in a blinded fashion, and a semi-quantitative histomorphometric analysis was performed. The parameters evaluated included the presence or absence of necrotic bone, inflammation, reactive bone formation, bacteria, and osteoclasts. No statistically significant differences were found between groups for any parameter. Necrotic bone was common to all three diagnoses. Inflammation and reactive bone formation were present in all three diagnoses. The presence of bacteria was a prominent feature in all cases. Osteoclasts were scarce in MRONJ and osteomyelitis, and non-existent in ORN. The results of this study failed to identify distinctive microscopic characteristics in any of the three entities that could be used to differentiate between them. Therefore, it is impossible to reach a specific final diagnosis based on microscopic findings alone. The role of microscopic analysis is to serve as an aid to diagnosis that must be complemented by the patients history and imaging.
Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology | 2015
Ilana Kaplan; Ilana Nabiochtchikov; Ari Leshno; Menachem Moshkowitz; Benjamin Shlomi; Shlomi Kleinman; Yaniv Dagan; Yaacob Meshiach; Lior Galazan; Nadir Arber; Limor Avivi-Arber; Sarah Kraus
OBJECTIVE CD24 and the adenomatous polyposis coli (APC) gene polymorphisms are known to predispose to malignant disease. We aimed to investigate their association with risk and susceptibility of oral lichen planus (OLP) in an Israeli Jewish population. STUDY DESIGN The study included 54 patients, of which 41 were females (75.9%) and 13 males (24.1%); of the 533 controls, 224 were females (42.0%) and 309 males (57.9%). Genotyping was performed. Two APC (I1307 K, E1317 Q) and four CD24 variants--C170 T (rs52812045), TG1527 del (rs3838646), A1626 G (rs1058881), and A1056 G (rs1058818)--were assessed. Frequencies were analyzed using the Chi-square test. Two-sided P < .05 values were considered significant. Odds ratios and 95% confidence intervals were obtained by logistic regression analyses. RESULTS CD24 A1056 G carriers have a significantly lower risk of OLP compared with individuals with the wild-type variant (P = .001). A significantly lower risk was found for heterozygote (P = .008) and homozygote carriers (P = .002). Homozygote CD24 A1626 G carriers had a significant higher risk for OLP compared with nonhomozygote carriers (P = .040). CD24 C170 T, TG1527 del, and APC polymorphisms did not show significant associations with OLP risk. CONCLUSIONS CD24 A1626 G is more frequent in OLP patients, contributes to disease risk, and could play a role in OLP susceptibility. A significant association between CD24 A1056 G and a lower OLP incidence was found, suggesting that it may confer protection against OLP risk and progression.
Journal of Oral and Maxillofacial Surgery | 2015
Vadim Reiser; Michael Alterman; Amir Shuster; Shlomi Kleinman; Benjamin Shlomi; Ravit Yanko-Arzi; Arik Zaretski; Aharon Amir; Dan M. Fliss
European Archives of Oto-rhino-laryngology | 2018
Omer J. Ungar; Daniel Yafit; Shlomi Kleinman; Vadim Raiser; Ahmad Safadi
Journal of Oral and Maxillofacial Surgery | 2017
Sara Whitefield; Vadim Raiser; Amir Shuster; Shlomi Kleinman; Benjamin Shlomi; Ilana Kaplan
Journal of Clinical Oncology | 2017
Tal Sella; Ben Boursi; Amira Gat-Charlap; Ilan Aroch; Eliezer Liberman; Menachem Moshkowitz; Ehud Miller; Eyal Gur; Arye Blachar; Nicola J. Mabjeesh; Fanny Sperber; Vadim Reiser; Shlomi Kleinman; Ariel J. Jaffa; Mati Ormianer; Inna Naumov; Diana Kazanov; Sarah Kraus; Lior Galazan; Nadir Arber
Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology | 2016
Ilana Kaplan; Shlomi Kleinman; G. Frenkel; D.M. Fliss; Benjamin Shlomi
Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology | 2015
Ilana Kaplan; Ilana Nabiochtchikov; M. Steiner; Ari Leshno; Menachem Moshkowitz; Benjamin Shlomi; Shlomi Kleinman; Yaniv Dagan; Lior Galazan; Nadir Arber; L. Avivi; Sarah Kraus